EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel NOX Inhibitor Alleviates Parkinson’s Disease Pathology in PFF-Injected Mice

Kwadwo Ofori, Anurupa Ghosh iD, Dinesh Kumar Verma iD, Darice Wheeler, Gabriela Cabrera, Jong-Bok Seo, Yong-Hwan Kim iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241814278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Kwadwo Ofori und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences/Neuroscience Program, Delaware State University, Dover, DE 19901, USA. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NINDS NIH HHS, ApatBio Therapeutics Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative stress-mediated damage is often a downstream result of Parkinson’s disease (PD), which is marked by sharp decline in dopaminergic neurons within the nigrostriatal regions of the brain, accounting for the symptomatic motor deficits in patients. Regulating the level of oxidative stress may present a beneficial approach in preventing PD pathology. Here, we assessed the efficacy of a nicotinamide adenine phosphate (NADPH) oxidase (NOX) inhibitor, an exogenous reactive oxygen species (ROS) regulator synthesized by Aptabio therapeutics with the specificity to NOX-1, 2 and 4. Utilizing N27 rat dopaminergic cells and C57Bl/6 mice, we confirmed that the exposures of alpha-synuclein preformed fibrils (PFF) induced protein aggregation, a hallmark in PD pathology. In vitro assessment of the novel compound revealed an increase in cell viability and decreases in cytotoxicity, ROS, and protein aggregation (Thioflavin-T stain) against PFF exposure at the optimal concentration of 10 nM. Concomitantly, the oral treatment alleviated motor-deficits in behavioral tests, such as hindlimb clasping, rotarod, pole, nesting and grooming test, via reducing protein aggregation, based on rescued dopaminergic neuronal loss. The suppression of NOX-1, 2 and 4 within the striatum and ventral midbrain regions including Substantia Nigra compacta (SNc) contributed to neuroprotective/recovery effects, making it a potential therapeutic option for PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseHumansMiceRatsAnimalsReactive Oxygen SpeciesProtein Aggregatesalpha-SynucleinBrainPars CompactaDopaminergic NeuronsDisease Models, AnimalMice, Inbred C57BL

Stichwörter der Autor:innen

cytotoxicityoxidative stressprotein aggregationreactive oxygen species (ROS)α-synuclein preformed fibrils (PFF)

Substanzen

Reactive Oxygen SpeciesProtein Aggregatesalpha-Synuclein

Autor:innen und Institutionen

  • Department of Biological Sciences/Neuroscience Program, Delaware State University, Dover, DE 19901, USA.
  • Seoul Center, Korea Basic Science Institute, Seongbuk-gu, Seoul 02841, Republic of Korea.

ORCID-Profile: Anurupa Ghosh, Dinesh Kumar Verma, Yong-Hwan Kim

Förderung

  • NIGMS NIH HHS
  • NINDS NIH HHS
  • ApatBio Therapeutics Inc
  • NIH-R15
  • NIH Delaware Neuroscience Center
  • NIH-U-RISE

Zitieren

APA

Ofori, K., Ghosh, A., Verma, D. K., Wheeler, D., Cabrera, G., Seo, J. B., & Kim, Y. H. (2023). A Novel NOX Inhibitor Alleviates Parkinson’s Disease Pathology in PFF-Injected Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241814278

Vancouver

Ofori K, Ghosh A, Verma DK, Wheeler D, Cabrera G, Seo JB, et al. A Novel NOX Inhibitor Alleviates Parkinson’s Disease Pathology in PFF-Injected Mice. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241814278

BibTeX
@article{Ofori2023,
  author = {Ofori, Kwadwo and Ghosh, Anurupa and Verma, Dinesh Kumar and Wheeler, Darice and Cabrera, Gabriela and Seo, Jong-Bok and Kim, Yong-Hwan},
  title = {A Novel NOX Inhibitor Alleviates Parkinson’s Disease Pathology in PFF-Injected Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241814278}
}
Kostenlos starten →